Alfresa Holdings Corporation (TYO:2784)
2,549.00
+11.50 (0.45%)
Feb 13, 2026, 11:30 AM JST
Alfresa Holdings Market Cap
Alfresa Holdings has a market cap or net worth of 461.11 billion as of February 12, 2026. Its market cap has increased by 19.24% in one year.
Market Cap
461.11B
Enterprise Value
268.88B
Revenue
3.06T
Ranking
n/a
PE Ratio
13.73
Stock Price
2,549.00
Market Cap Chart
Since November 19, 2003, Alfresa Holdings's market cap has increased from 132.81B to 461.11B, an increase of 247.18%. That is a compound annual growth rate of 5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 461.11B | 4.38% |
| Dec 30, 2025 | 441.76B | 9.22% |
| Dec 30, 2024 | 404.46B | -9.83% |
| Dec 29, 2023 | 448.56B | 32.25% |
| Dec 30, 2022 | 339.17B | 5.55% |
| Dec 30, 2021 | 321.33B | -19.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 15.02T |
| HOYA Corporation | 9.51T |
| Takeda Pharmaceutical Company | 8.69T |
| Daiichi Sankyo Company | 5.45T |
| MediPal Holdings | 598.74B |
| COSMOS Pharmaceutical | 576.36B |
| Santen Pharmaceutical | 555.69B |
| Sundrug | 495.07B |